Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance

ClinicalTrials.gov ID: NCT02799745

Public ClinicalTrials.gov record NCT02799745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:35 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT)

Study identification

NCT ID
NCT02799745
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Astellas Pharma Global Development, Inc.
Industry
Enrollment
227 participants

Conditions and interventions

Interventions

  • Active Surveillance Other
  • Enzalutamide Drug

Other · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 8, 2016
Primary completion
Aug 27, 2020
Completion
Aug 27, 2020
Last update posted
Dec 5, 2024

2016 – 2020

United States locations

U.S. sites
50
U.S. states
25
U.S. cities
44
Facility City State ZIP Site status
Site US10034 Birmingham Alabama 35223
Site US10024 Homewood Alabama 35209
Site US10007 Tucson Arizona 85704
Site US10055 Tucson Arizona 85741
Site US10004 Los Angeles California 90048
Site US10026 Sacramento California 95670
Site US10010 San Diego California 92123
Site US10051 Aurora Colorado 80045
Site US10029 Denver Colorado 80211
Site US10054 Denver Colorado 80220
Site US10072 Bradenton Florida 34205
Site US10057 Lakeland Florida 33805
Site US10038 Chicago Illinois 60611
Site US10062 Chicago Illinois 60612
Site US10074 Chicago Illinois 60612
Site US10018 Glenview Illinois 60026
Site US10071 Lake Barrington Illinois 60010
Site US10046 Carmel Indiana 46033
Site US10009 Jeffersonville Indiana 47130
Site US10037 New Orleans Louisiana 70112
Site US10006 Shreveport Louisiana 71106
Site US10001 Towson Maryland 21204
Site US10032 Boston Massachusetts 02111
Site US10008 Troy Michigan 48084
Site US10069 Lincoln Nebraska 68516
Site US10044 Omaha Nebraska 68114
Site US10067 Omaha Nebraska 68130
Site US10061 Lebanon New Hampshire 03756
Site US10049 Morristown New Jersey 07962
Site US10043 Voorhees Township New Jersey 08043
Site US10068 Brooklyn New York 11215
Site US10050 Cheektowaga New York 14225
Site US10030 Garden City New York 11530
Site US10028 Poughkeepsie New York 12601
Site US10021 Syracuse New York 13210
Site US10022 Syracuse New York 13210
Site US10047 Gastonia North Carolina 28053
Site US10045 Cleveland Ohio 44195
Site US10015 Middleburg Heights Ohio 44130
Site US10053 Oklahoma City Oklahoma 73104
Site US10063 Bala-Cynwyd Pennsylvania 19004
Site US10052 Lancaster Pennsylvania 17604
Site US10014 Warwick Rhode Island 02886
Site US10019 Myrtle Beach South Carolina 29572
Site US10011 Nashville Tennessee 37209
Site US10056 Dallas Texas 75231
Site US10036 Houston Texas 77027
Site US10035 San Antonio Texas 78229
Site US10058 Richmond Virginia 23235
Site US10017 Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02799745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 5, 2024 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02799745 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →